2006
DOI: 10.1161/01.str.0000200558.38774.d5
|View full text |Cite
|
Sign up to set email alerts
|

Advances in Subarachnoid Hemorrhage

Abstract: A lthough subarachnoid hemorrhage (SAH) comprises only 1% to 7% of all strokes, 1 the loss of productive life years in the general population from SAH is comparable to that of cerebral infarction 2 because of the relatively young age of onset and poor outcome in SAH. 1,3,4 However, unlike other stroke subtypes, the incidence of SAH exhibits little geographical variation and did not significantly change over the last decades. 1 In the most recent overview of 14 longitudinal and 23 case-control studies of risk f… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
18
0
2

Year Published

2009
2009
2017
2017

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 37 publications
(21 citation statements)
references
References 81 publications
1
18
0
2
Order By: Relevance
“…1,2 CA is a relatively common disease with a prevalence ranging from 1 to 5% in a large autopsy series. 3 Despite its clinical and public importance, the detailed mechanisms of the initiation, progression and rupture of CAs remain to be elucidated, resulting in the absence of effective medical treatment for CAs.…”
mentioning
confidence: 99%
“…1,2 CA is a relatively common disease with a prevalence ranging from 1 to 5% in a large autopsy series. 3 Despite its clinical and public importance, the detailed mechanisms of the initiation, progression and rupture of CAs remain to be elucidated, resulting in the absence of effective medical treatment for CAs.…”
mentioning
confidence: 99%
“…(Junaidi, 2006). Jika tidak ada upaya penanggulangan stroke yang lebih baik maka jumlah penderita stroke pada tahun 2020 diprediksikan akan meningkat 2 kali lipat (Feigin, 2006).…”
Section: Pendahuluanunclassified
“…The protection of brain tissue after traumatic or ischemic events poses a current challenge for critical neurological care in medical centers worldwide [1][2][3][4][5]. The goal of neuroprotection is to preserve viable areas of brain tissue in the event of injury in order to restore performance to levels as close as possible to their original physiological functions.…”
Section: Introductionmentioning
confidence: 99%
“…Reduction of cellular metabolism and stimulation of trophic properties in these cells is conducive to achieving a new balance for cellular viability. To this end, many types of pharmacological and physical interventions have been employed in intensive care units [1][2][3][4][5][6][7][8][9]. However, real benefits of the current treatments are far from ideal, particularly given the difficulties in inhibiting the inexorable cascade triggered by the initial event and in controlling the complications associated with treatment options [4].…”
Section: Introductionmentioning
confidence: 99%